GL1X · GenesisL1 explorer

Ligand · VK5

VK5 · ~{N}-[[3-[4-[(dimethylamino)methyl]phenyl]imidazo[1,2-a]pyridin-6-yl]methyl]-~{N}-methyl-5-[3-methyl-5-(1,3, 5-trimethylpyrazol-4-yl)pyridin-2-yl]-1,3,4-oxadiazol-2-amine

VK5, ~{N}-[[3-[4-[(dimethylamino)methyl]phenyl]imidazo[1,2-a]pyridin-6-yl]methyl]-~{N}-methyl-5-[3-methyl-5-(1,3, 5-trimethylpyrazol-4-yl)pyridin-2-yl]-1,3,4-oxadiazol-2-amine (C32 H35 N9 O, 561.7 g/mol), in the MolNFT structures on…

Component
VK5
Formula
C32 H35 N9 O
Class
ligand
Structures
1
PDB entries
1

Binding sites

VK5 in 1 structure; the first of them:

  • 7OLX · Mertk kinase domain with type 1.5 inhibitor containing a tri-methyl pyrazole group · VK5 A901 · binds LEU593, VAL601, ALA617, LYS619, MET621, PHE634, GLU637, ALA638 and 12 more

Residues it binds most

MET 1, ALA 1, LEU 1, PHE 1, VAL 1, ASP 1, GLU 1, ILE 1, LYS 1, PRO 1 (residue and the binding sites it lines).

Found with

  • CL · Chloride ion

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.